Collaborative Culture Sample Clauses

Collaborative Culture. Essential to successful outcomes is a culture of professional empowerment, mutual accountability, and collaborative decision-making. The instructional program will include PLCs that are embedded in the school’s daily schedule. During the enrichment periods, homeroom teachers, teacher leaders, and instructional coaches meet regularly to support teaching and learning through: (1) data meetings to review student progress and adjust instruction in core academic subjects (e.g., language/literacy and math development, science, social studies) to address student learning problems; (2) lesson design conversations that strive to integrate research-based instructional strategies; and (3) create common formative assessments to ensure student mastery of essential standards. These communities of practice encourage teacher-driven innovation at the school across instruction, operations and policy (Xxxxxxx X. Xxxxxxx and Xxxxxxx X. Xxxxxx, Harvard Business Review, 2000)). A teacher leadership structure in each grade level through Academic Integration Specialists (AIS) will expand the capacity for PLCs to thrive. These teachers will be supported to lead their own teams in PLC’s. This initiative expands the capacity for professional learning and develops leadership capacity in teachers. These teacher leaders will be provided with additional intensive training on coaching and facilitating PLC’s. The enrichment program provides collaborative time daily for teachers to work on instructional goals that are data-driven.
Sample 1
AutoNDA by SimpleDocs
Collaborative Culture. To strengthen collaborative culture, staff are provided with opportunities to work collaboratively with teachers, coaches and mentors across the Waikerie Partnership and system. Peer /coach/ leader/mentor Observations  Teachers analyse data, design and evaluate teaching plans as a school team and through the Waikerie Partnership.  All teachers are regularly provided with the opportunity to observe each other’s literacy practice and receive and give feedback through coaching and mentoring at least once per term.
Sample 1
Collaborative Culture. THE CONSULTATIVE COMMITTEE 42.1. The Consultative Committee will oversee the Agreement by actively ensuring the commitments made are achieved. Appropriate training will be provided to the Consultative Committee members to assist them in their role. Meetings: Communication/Meetings The parties agree that communication is a continuous improvement issue and the responsibility of all who comprise the enterprise.
Sample 1
Collaborative Culture. 26 Obstructions .................................................................................................. 27 Implementations ............................................................................................ 31 Conclusion .................................................................................................... 34 The Influences of Effective Leadership .................................................................... 34
Sample 1
Collaborative Culture. 37 High-Needs Schools...................................................................................... 38 Obstructions .................................................................................................. 39 Conclusion .................................................................................................... 40 Central Office Structures to Create the Conditions for Principals to Serve as Learning Leaders .............................................................................................................. 40
Sample 1
Collaborative Culture. 44 The Dimensions of Central Office Transformation .................................................. 44 Dimension 1 .................................................................................................. 45 Dimension 2 .................................................................................................. 46 Dimension 3 .................................................................................................. 46 Dimension 4 .................................................................................................. 46 Dimension 5 .................................................................................................. 47 District Results .............................................................................................. 47 Models from High-Achieving Districts ........................................................ 49
Sample 1
Collaborative Culture. The research on professional learning communities (PLCs) is clear. When teachers participate in effective PLCs, student learning increases (XxXxxx et al., 2006; XxXxxx & Xxxxxx, 2013; The Xxxxxxx Foundation, 2013). In addition, “Principals play a major role in developing a professional community of teachers who guide one another in improving instruction” (The Xxxxxxx Foundation, 2013, p. 9). However, it is important to note that simply providing time for teachers to engage with colleagues will not impact student achievement. The collaborative sessions must focus on the right work (Xxxxxxxx, Xxxxxxxxxx, & Xxxxxxxxx, 2009, as cited in XxXxxx & Xxxxxx, 2013). While we know the core of effective PLC conversations should revolve around the four questions of a PLC (DuFour, DuFour, & Xxxxx, 2008), XxXxxx and Xxxxxx (2013) highlighted four strategies for principals to utilize in their efforts to ensure a positive collaborative culture: form teams where members share responsibility for all student learning; provide teams with time to work together; clarify the work of establishing a guaranteed
Sample 1
AutoNDA by SimpleDocs

Related to Collaborative Culture

  • Research Project 3.1 These Materials and Data will be used by Recipient's PI solely in connection with the Research Project, as named and described in the attached research application (insert Research Project name below):

  • Collaboration We believe joint effort toward common goals achieves trust and produces greater impact for L.A. County’s youngest children and their families.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • For Product Development Projects and Project Demonstrations  Published documents, including date, title, and periodical name.  Estimated or actual energy and cost savings, and estimated statewide energy savings once market potential has been realized. Identify all assumptions used in the estimates.  Greenhouse gas and criteria emissions reductions.  Other non-energy benefits such as reliability, public safety, lower operational cost, environmental improvement, indoor environmental quality, and societal benefits.  Data on potential job creation, market potential, economic development, and increased state revenue as a result of the project.  A discussion of project product downloads from websites, and publications in technical journals.  A comparison of project expectations and performance. Discuss whether the goals and objectives of the Agreement have been met and what improvements are needed, if any.

  • Development Phase contractual phase initiated with the approval of ANP for the Development Plan and which is extended during the Production Phase while investments in xxxxx, equipment, and facilities for the Production of Oil and Gas according to the Best Practices of the Oil Industry are required.

  • Development Plan document specifying the work program, schedule, and relevant investments required for the Development and the Production of a Discovery or set of Discoveries of Oil and Gas in the Contract Area, including its abandonment.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, or the results of which are referred to in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMEA, Health Canada and other comparable drug and medical device (including diagnostic product) regulatory agencies outside of the United States to which they are subject; the descriptions of the results of such studies, tests and trials contained in the Registration Statement, the Time of Sale Disclosure Package or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Disclosure Package and the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement, the Time of Sale Disclosure Package or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMEA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement, the Time of Sale Disclosure Package and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Research Use The Requester agrees that if access is approved, (1) the PI named in the DAR and (2) those named in the “Senior/Key Person Profile” section of the DAR, including the Information Technology Director and any trainee, employee, or contractor1 working on the proposed research project under the direct oversight of these individuals, shall become Approved Users of the requested dataset(s). Research use will occur solely in connection with the approved research project described in the DAR, which includes a 1-2 paragraph description of the proposed research (i.e., a Research Use Statement). Investigators interested in using Cloud Computing for data storage and analysis must request permission to use Cloud Computing in the DAR and identify the Cloud Service Provider (CSP) or providers and/or Private Cloud System (PCS) that they propose to use. They must also submit a Cloud Computing Use Statement as part of the DAR that describes the type of service and how it will be used to carry out the proposed research as described in the Research Use Statement. If the Approved Users plan to collaborate with investigators outside the Requester, the investigators at each external site must submit an independent DAR using the same project title and Research Use Statement, and if using the cloud, Cloud Computing Use Statement. New uses of these data outside those described in the DAR will require submission of a new DAR; modifications to the research project will require submission of an amendment to this application (e.g., adding or deleting Requester Collaborators from the Requester, adding datasets to an approved project). Access to the requested dataset(s) is granted for a period of one (1) year, with the option to renew access or close-out a project at the end of that year. Submitting Investigator(s), or their collaborators, who provided the data or samples used to generate controlled-access datasets subject to the NIH GDS Policy and who have Institutional Review Board (IRB) approval and who meet any other study specific terms of access, are exempt from the limitation on the scope of the research use as defined in the DAR.

  • Additional Information for Product Development Projects Outcome of product development efforts, such copyrights and license agreements. • Units sold or projected to be sold in California and outside of California. • Total annual sales or projected annual sales (in dollars) of products developed under the Agreement. • Investment dollars/follow-on private funding as a result of Energy Commission funding. • Patent numbers and applications, along with dates and brief descriptions.  Additional Information for Product Demonstrations: • Outcome of demonstrations and status of technology. • Number of similar installations. • Jobs created/retained as a result of the Agreement.

Time is Money Join Law Insider Premium to draft better contracts faster.